Three Pharmacy Regulations Health Execs Should Watch

Edward Buthusiem comments on the Orphan Drug Act designation and its benefits and incentives; the volume and costs of producing and selling orphan drugs; and the pending Closing Loopholes for Orphan Drugs Act.

Read the article.